Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EXEMESTANE vs LETROZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EXEMESTANE vs LETROZOLE: Safety Overview

Metric EXEMESTANE LETROZOLE
Total FAERS Reports 10,418 31,154
Deaths Reported 1,256 3,024
Death Rate 12.1% 9.7%
Hospitalizations 2,327 8,637
Average Patient Age 64.2 yrs 61.8 yrs
% Female Patients 98.7% 98.9%
FDA Approval Date Apr 1, 2011 Apr 19, 2012
Manufacturer Zydus Lifesciences Limited NuCare Pharmaceuticals,Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription